American Society of Clinical Oncology Policy Statement: Disparities in Cancer Care

被引:110
|
作者
Goss, Elizabeth
Lopez, Ana Maria
Brown, Carol L.
Wollins, Dana S.
Brawley, Otis W.
Raghavan, Derek
机构
[1] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH 44106 USA
[2] Amer Canc Soc, Atlanta, GA 30329 USA
[3] Amer Soc Clin Oncol, Alexandria, VA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
[5] Arizona Canc Ctr, Tucson, AZ USA
[6] Turner & Goss LLP, Washington, DC USA
关键词
D O I
10.1200/JCO.2008.21.1680
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The American Society of Clinical Oncology (ASCO) has embarked on an intensive campaign to integrate elimination of cancer health disparities into the Society's overall mission and activities. Key components of this commitment are enhancing awareness of disparities; improving access to care; and supporting research on health disparities. Major objectives are to advance the education of the oncology community in the care of patients from underserved and minority populations; increase the diversity of the clinical oncology workforce as a requisite to improving access to cancer care for the underserved; and support research in the area of health disparities. Racial and ethnic disparities in cancer care are an issue of critical importance to ASCO, the oncology community, and our society at large. The health disparities initiative outlined herein enunciates ASCO's dedication to eliminating disparities in cancer care and discusses our multipronged approach for addressing disparities within the clinical oncology community. ASCO is committed to collaborating with the diverse community of stakeholders to undertake the following: develop policies to guarantee equal access to quality health care, with special emphasis on reducing insurance and economic barriers to cancer care; develop a comprehensive plan to increase awareness of racial and ethnic disparities in cancer care; execute a strategy to enhance the supply of minority physicians and to improve the training of the oncology workforce to meet the needs of racially and ethnically diverse cancer patients; increase prioritization of public and private research on cancer care disparities; develop mechanisms to increase participation of racially and ethnically diverse populations in cancer clinical trials; and support initiatives to enhance patients' involvement in their cancer care.
引用
收藏
页码:2881 / 2885
页数:5
相关论文
共 50 条
  • [41] American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations
    Griggs, Jennifer
    Maingi, Shail
    Blinder, Victoria
    Denduluri, Neelima
    Khorana, Alok A.
    Norton, Larry
    Francisco, Michael
    Wollins, Dana S.
    Rowland, Julia H.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (19) : 2203 - +
  • [44] American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment
    Weber, Jeffrey S.
    Levit, Laura A.
    Adamson, Peter C.
    Bruinooge, Suanna
    Burris, Howard A.
    Carducci, Michael A.
    Dicker, Adam P.
    Goenen, Mithat
    Keefe, Stephen M.
    Postow, Michael A.
    Thompson, Michael A.
    Waterhouse, David M.
    Weiner, Susan L.
    Schuchter, Lynn M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 278 - U83
  • [45] Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement
    Tsimberidou, Apostolia M.
    Levit, Laura A.
    Schilsky, Richard L.
    Averbuch, Steven D.
    Chen, Daniel
    Kirkwood, John M.
    McShane, Lisa M.
    Sharon, Elad
    Mileham, Kathryn F.
    Postow, Michael A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (01) : 72 - +
  • [46] Trial Reporting in Immuno-Oncology (TRIO): an American society of clinical oncology-society for immunotherapy of cancer statement
    Tsimberidou, Apostolia M.
    Levit, Laura A.
    Schilsky, Richard L.
    Averbuch, Steven D.
    Chen, Daniel
    Kirkwood, John M.
    McShane, Lisa M.
    Sharon, Elad
    Mileham, Kathryn F.
    Postow, Michael A.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [47] Tobacco Cessation and Control a Decade Later: American Society of Clinical Oncology Policy Statement Update
    Hanna, Nasser
    Mulshine, James
    Wollins, Dana S.
    Tyne, Courtney
    Dresler, Carolyn
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (25) : 3147 - +
  • [48] Policy Statement on the 340B Drug Pricing Program by the American Society of Clinical Oncology
    Tomkins, Julia E.
    JOURNAL OF ONCOLOGY PRACTICE, 2014, 10 (04) : 259 - 263
  • [49] American Society of Clinical Oncology Expert Statement: Collection and Use of a Cancer Family History for Oncology Providers
    Lu, Karen H.
    Wood, Marie E.
    Daniels, Molly
    Burke, Cathy
    Ford, James
    Kauff, Noah D.
    Kohlmann, Wendy
    Lindor, Noralane M.
    Mulvey, Therese M.
    Robinson, Linda
    Rubinstein, Wendy S.
    Stoffel, Elena M.
    Snyder, Carrie
    Syngal, Sapna
    Merrill, Janette K.
    Wollins, Dana Swartzberg
    Hughes, Kevin S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (08) : 833 - +
  • [50] International Society for Pharmacoepidemiology (ISPE) statement on American Society of Clinical Oncology's new policy for relationships with companies
    Acquavella, John
    Sturmer, Til
    Hallas, Jesper
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (01) : 1 - 2